China Pharma Holdings reported that it expects to implement a 1-for-5 reverse stock split on its common stock effective Wednesday, March 6, with trading to begin on a split-adjusted basis at the market open on that day. Trading in the common stock will continue on the NYSE American under the symbol “CPHI“. The reverse stock split at a ratio of 1-for-5 shares was approved by the company’s board through unanimous written consent on October 16, 2023 and adopted by the company’s stockholders through annual meeting for the fiscal year ended on December 31, 2022, which was held on December 17, 2023.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CPHI: